SAN FRANCISCO, March 5, 2025 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2024 on Wednesday, March 12, 2025, after the close of U.S.-based financial markets. Howard Robin, President and Chief…

WASHINGTON, March 5, 2025 /PRNewswire/ — Paralyzed Veterans of America Chief Executive Officer Carl Blake releases statement following the leak of an internal memo revealing the Department of Veterans Affairs’ plan to reduce its overall staffing of the department to FY 2019 levels – a…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.